Zymeworks

(NASDAQ) ZYME

Current Price$23.93

Market Cap$1.78B

Since IPO (2017)+84%

5 Year-21%

1 Year+111%

1 Month-11%

Zymeworks Financials at a Glance

Market Cap

$1.78B

Revenue (TTM)

$81.26M

Net Income (TTM)

$102.66M

EPS (TTM)

$-1.37

P/E Ratio

-17.47

Dividend

$0.00

Beta (Volatility)

0.98 (Low)

Dividend

$0.00

Beta (Volatility)

0.98 (Low)

Price

$23.93

Volume

1,454,524.838

Open

$26.21

Price

$23.93

Volume

1,454,524.838

Open

$26.21

Previous Close

$23.89

Daily Range

$23.39 - $26.21

52-Week Range

$10.93 - $29.75

Dividend

$0.00

Beta (Volatility)

0.98 (Low)

Price

$23.93

Volume

1,454,524.838

Open

$26.21

Previous Close

$23.89

Daily Range

$23.39 - $26.21

52-Week Range

$10.93 - $29.75

ZYME News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zymeworks

Industry

Biotechnology

Sector

Health Care

Employees

243

CEO

Ken Galbraith

Website

www.zymeworks.com

Headquarters

Middletown, BC V5T 1G4, CA

ZYME Financials

Key Financial Metrics (TTM)

Gross Margin

94%

Operating Margin

-1%

Net Income Margin

-1%

Return on Equity

-42%

Return on Capital

-0%

Return on Assets

-0%

Earnings Yield

-5.72%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.78B

Shares Outstanding

74.30M

Volume

1.45M

Avg. Volume

647.16K

Financials (TTM)

Gross Profit

$105.97M

Operating Income

$92.53M

EBITDA

$81.42M

Operating Cash Flow

$33.01M

Capital Expenditure

$1.52M

Free Cash Flow

$34.53M

Cash & ST Invst.

$228.80M

Total Debt

$18.27M

Zymeworks Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$2.41M

-91.1%

Gross Profit

$439.00K

-101.6%

Gross Margin

-18.23%

N/A

Market Cap

$1.78B

N/A

Market Cap/Employee

$5.94M

N/A

Employees

299

N/A

Net Income

$44.16M

-95.1%

EBITDA

$44.27M

-98.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$347.69B

+140761.8%

Accounts Receivable

$4.67B

+18904.6%

Inventory

$0.00

N/A

Long Term Debt

$13.78B

+90524.7%

Short Term Debt

$3.28B

+100544.6%

Return on Assets

-0.02%

N/A

Return on Invested Capital

-0.03%

N/A

Free Cash Flow

$45.72B

-1220674.4%

Operating Cash Flow

$45.72B

-1341784.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BCRXBioCryst Pharmaceuticals, Inc.

BCRXBioCryst Pharmaceuticals, Inc.$8.62-3.15%

ARDXArdelyx, Inc.

ARDXArdelyx, Inc.$6.78-2.87%

NTLAIntellia Therapeutics, Inc.

NTLAIntellia Therapeutics, Inc.$14.09+2.77%

PHVSPharvaris N.V.

PHVSPharvaris N.V.$30.09+1.38%

IMNMImmunome, Inc.

IMNMImmunome, Inc.$22.44+1.13%

TRVITrevi Therapeutics, Inc.

TRVITrevi Therapeutics, Inc.$14.50+3.20%

MAZEMaze Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.$26.03+2.20%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

IRENIren

IRENIren$61.20+0.08%

NOKNokia

NOKNokia$12.82+0.04%

POETPoet Technologies

POETPoet Technologies$10.95+0.14%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

Questions About ZYME

What is the current price of Zymeworks?

Zymeworks is trading at $23.89 per share.

What is the 52-week range for Zymeworks?

Over the past 52 weeks, Zymeworks has traded between $10.93 and $29.75.

How much debt does Zymeworks have?

As of the most recent reporting period, Zymeworks reported total debt of $263.55M.

How much cash does Zymeworks have on hand?

Zymeworks reported $244.28M in cash and cash equivalents in its most recent financial results.

What is Zymeworks’s dividend yield?

Zymeworks does not currently have a dividend yield.

Zymeworks

Zymeworks Financials at a Glance

ZYME News

Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year

Why Shares of Zymeworks Rose 12.18% on Monday

Why Zymeworks Stock Is Soaring Today

Why Zymeworks Stock Is Rocketing Higher on Friday

Is It Too Late to Buy Zymeworks Stock?

Why Zymeworks Stock Is Crashing Today

3 Top Biotech Picks for 2025

Billionaires Are Gobbling Up These 3 Healthcare Stocks

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Zymeworks

ZYME Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Zymeworks Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ZYME

What is the current price of Zymeworks?

What is the 52-week range for Zymeworks?

How much debt does Zymeworks have?

How much cash does Zymeworks have on hand?

What is Zymeworks’s dividend yield?

Premium Investing Services